Stephanie S Faubion, MD, FACP, NCMP, IF
Director, Executive and International Medicine
Director, Office of Women’s Health
Professor of Medicine
Division of General Internal Medicine
Mayo Clinic, Rochester, Minnesota
Dr Faubion discusses what options a clinician has for the treatment of GSM in survivors of breast cancer or in those at high risk of breast cancer.
Content updated 22 May 2019